Houdek Matthew T, Watts Chad D, Wyles Cody C, Martin John R, Trousdale Robert T, Taunton Michael J
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota.
J Arthroplasty. 2017 Mar;32(3):836-842. doi: 10.1016/j.arth.2016.09.036. Epub 2016 Oct 5.
Biomechanical studies have suggested improved stress distribution in metal-backed (MB) compared to all-polyethylene (AP) tibias, but such potential benefits have not been realized clinically. The purpose of this investigation was to analyze the outcomes of AP components in patients with primary osteoarthritis and compare the results to those obtained with MB tibial components in total knee arthroplasty (TKA).
We reviewed 11,653 patients undergoing primary TKA for osteoarthritis. There were 9999 (86%) MB (8470 modular and 1529 monoblock) and 1654 (14%) AP tibial components. All patients had at least 2 years of clinical follow-up with mean follow-up of 8 years (range, 2-30 years).
Mean survivorship for all primary TKAs at the 5-year, 10-year, 15-year, and 20-year time points was 97%, 92%, 86%, and 78%. AP tibial components were found to have improved survivorship when compared to modular and monoblock MB counterparts (P < .0001). Likewise, AP tibial components were found to have lower rates of tibial component loosening (P < .0001), tibial osteolysis, and component fracture. Furthermore, the AP group had improved survival rates in most age-groups except <55 years where there was no difference. AP tibial components demonstrated improved survival for all body mass index (BMI) groups except in patients with a BMI ≤25 kg/m where there was no difference.
AP tibial components had significantly improved implant survival across all age-groups and most BMI categories in patients who underwent TKA for osteoarthritis. Given these outcomes, AP tibias are a reasonable option, regardless of patient age and BMI.
生物力学研究表明,与全聚乙烯(AP)胫骨假体相比,金属背衬(MB)胫骨假体的应力分布有所改善,但这种潜在益处尚未在临床上得到体现。本研究的目的是分析原发性骨关节炎患者使用AP假体的结果,并将其与全膝关节置换术(TKA)中使用MB胫骨假体的结果进行比较。
我们回顾了11653例因骨关节炎接受初次TKA的患者。其中有9999例(86%)使用MB胫骨假体(8470例模块化和1529例整体式),1654例(14%)使用AP胫骨假体。所有患者均有至少2年的临床随访,平均随访时间为8年(范围2 - 30年)。
所有初次TKA在5年、10年、15年和20年时间点的平均生存率分别为97%、92%、86%和78%。与模块化和整体式MB胫骨假体相比,AP胫骨假体的生存率有所提高(P <.0001)。同样,AP胫骨假体的胫骨部件松动率(P <.0001)、胫骨骨溶解和部件骨折发生率较低。此外,除<55岁年龄组无差异外,AP组在大多数年龄组中的生存率有所提高。AP胫骨假体在所有体重指数(BMI)组中均表现出生存率提高,除了BMI≤25 kg/m²的患者无差异。
在因骨关节炎接受TKA的患者中,AP胫骨假体在所有年龄组和大多数BMI类别中均显著提高了植入物的生存率。鉴于这些结果,无论患者年龄和BMI如何,AP胫骨假体都是一个合理的选择。